Report of the expert committee on the diagnosis and classification of diabetes mellitus.

the growth of knowledge regarding the etiology and pathogenesis of diabetes has led many individuals and groups in the diabetes community to express the need for a revision of the nomenclature, diagnostic criteria, and classification of diabetes. As a consequence, it was deemed essential to develop an appropriate, uniform terminology and a functional, working classification of diabetes that reflects the current knowledge about the disease. (1)

[1]  M. Shipley,et al.  CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.

[2]  P. Gruppuso,et al.  Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin. , 1984, The New England journal of medicine.

[3]  H. Keen,et al.  The Bedford Survey: observations on retina and lens of subjects with impaired glucose tolerance and in controls with normal glucose tolerance. , 1983, Diabete & metabolisme.

[4]  I. Ernest,et al.  Long-term results in 64 patients operated upon for pheochromocytoma. , 2009, Acta medica Scandinavica.

[5]  M. Rowley,et al.  Pancreatic Islet Cell Cytoplasmic Antibody in Diabetes is Represented by Antibodies to Islet Cell Antigen 512 and Glutamic Acid Decarboxylase , 1995, Diabetes.

[6]  B. Metzger,et al.  Prepregnancy Weight and Antepartum Insulin Secretion Predict Glucose Tolerance Five Years After Gestational Diabetes Mellitus , 1993, Diabetes Care.

[7]  M. Pembrey,et al.  Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA , 1992, The Lancet.

[8]  Rena R Wing,et al.  Caloric Restriction Per Se Is a Significant Factor in Improvements in Glycemic Control and Insulin Sensitivity During Weight Loss in Obese NIDDM Patients , 1994, Diabetes Care.

[9]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[10]  A. Kissebah,et al.  Relation of body fat distribution to metabolic complications of obesity. , 1982, The Journal of clinical endocrinology and metabolism.

[11]  F. Doyle,et al.  The Acromegaly Syndrome , 1982 .

[12]  J. Olefsky,et al.  Diabetes due to secretion of an abnormal insulin. , 1980, The New England journal of medicine.

[13]  A. Floreani,et al.  Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis , 1992, The Lancet.

[14]  Guido Davidzon,et al.  Mitochondrial DNA and disease , 2005, Annals of medicine.

[15]  G. Reaven,et al.  Nonketotic diabetes mellitus: insulin deficiency or insulin resistance? , 1976, The American journal of medicine.

[16]  L. Khan,et al.  Insulin therapy for diabetic ketoacidosis. , 2002, Saudi medical journal.

[17]  Å. Lernmark,et al.  Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. , 1995, The Journal of clinical investigation.

[18]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[19]  M. Myers,et al.  Inhibition of Mitochondrial Complex I May Account for IDDM Induced by Intoxication With the Rodenticide Vacor , 1996, Diabetes.

[20]  D. Coustan,et al.  Are the Current ACOG Glucose Tolerance Test Criteria Sensitive Enough? , 1991, Obstetrics and gynecology.

[21]  Diabetes in identical twins , 1981, Diabetologia.

[22]  J. Olefsky,et al.  A structurally abnormal insulin causing human diabetes , 1979, Nature.

[23]  S. Carr,et al.  Gestational diabetes: predictors of subsequent disordered glucose metabolism. , 1993, American journal of obstetrics and gynecology.

[24]  D. Grobbee,et al.  Why Use the Oral Glucose Tolerance Test? , 1995, Diabetes Care.

[25]  V. Klein,et al.  Efficacy of screening for gestational diabetes. , 1985, American journal of perinatology.

[26]  P. Zimmet,et al.  Determining Diabetes Prevalence: a Rational Basis for the Use of Fasting Plasma Glucose Concentrations? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[27]  M. Berkus,et al.  Intensified versus conventional management of gestational diabetes. , 1994, American journal of obstetrics and gynecology.

[28]  J. Beckmann,et al.  A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q , 1995, Nature Genetics.

[29]  J. O'sullivan.  The Boston Gestational Diabetes Studies: Review and Perspectives , 1989 .

[30]  W. Rayburn,et al.  Gestational diabetes screening in a private, midwestern American population. , 1987, American journal of obstetrics and gynecology.

[31]  M. Laakso,et al.  NIDDM and Its Metabolic Control Predict Coronary Heart Disease in Elderly Subjects , 1994, Diabetes.

[32]  J. Maassen,et al.  Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness , 1992, Nature Genetics.

[33]  A. Voller,et al.  COXSACKIE-B-VIRUS-SPECIFIC IgM RESPONSES IN CHILDREN WITH INSULIN-DEPENDENT (JUVENILE-ONSET; TYPE I) DIABETES MELLITUS , 1983, The Lancet.

[34]  D. Sacks,et al.  Do the current standards for glucose tolerance testing in pregnancy represent a valid conversion of O'Sullivan's original criteria? , 1989, American journal of obstetrics and gynecology.

[35]  T D Hockaday,et al.  Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations. , 1979, Metabolism: clinical and experimental.

[36]  D. McIntire,et al.  Class A1 Gestational Diabetes: A Meaningful Diagnosis? , 1993, Obstetrics and gynecology.

[37]  G. Reach,et al.  Diabetes Mellitus Following Pentamidine-induced Hypoglycemia in Humans , 1982, Diabetes.

[38]  C. Taylor,et al.  Glucose intolerance in cystic fibrosis. , 1989, Archives of disease in childhood.

[39]  Influence of diagnostic criteria on the incidence of gestational diabetes and perinatal morbidity. , 1993, JAMA.

[40]  J. A. Scarlett,et al.  Insulin Treatment Reverses the Insulin Resistance of Type II Diabetes Mellitus , 1982, Diabetes Care.

[41]  R. Klein,et al.  Visual Impairment and Retinopathy in People With Normal Glucose Tolerance, Impaired Glucose Tolerance, and Newly Diagnosed NIDDM , 1991, Diabetes Care.

[42]  G. Reaven,et al.  Does hyperglycaemia or hyperinsulinaemia characterise the patient with chemical diabetes? , 1972, Lancet.

[43]  R. Sakuta,et al.  A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. , 1994, The New England journal of medicine.

[44]  C. Kahn,et al.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. , 1976, The New England journal of medicine.

[45]  A. Kinugasa.  [Genetic syndromes associated with glucose intolerance]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[46]  J. Conn.  Hypertension, the potassium ion and impaired carbohydrate tolerance. , 1965, The New England journal of medicine.

[47]  C. Deerochanawong,et al.  Comparison of National Diabetes Data Group and World Health Organization criteria for detecting gestational diabetes mellitus , 1996, Diabetologia.

[48]  P. Zimmet.  Kelly West Lecture 1991 Challenges in Diabetes Epidemiology—From West to the Rest , 1992, Diabetes Care.

[49]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[50]  M. King,et al.  Concordance for Type 2 (non-insulin-dependent) diabetes mellitus in male twins , 1987, Diabetologia.

[51]  W. Knowler,et al.  Relationship of Glycosylated Hemoglobin to Oral Glucose Tolerance: Implications for Diabetes Screening , 1988, Diabetes.

[52]  M. Harris,et al.  Undiagnosed NIDDM: Clinical and Public Health Issues , 1993, Diabetes Care.

[53]  R. Klein,et al.  The association of glycemia and cause-specific mortality in a diabetic population. , 1994, Archives of internal medicine.

[54]  J. Krischer,et al.  GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. , 1994, Journal of autoimmunity.

[55]  P. Bennett,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr , 1987, Diabetes.

[56]  R. DeFronzo,et al.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. , 1979, The Journal of clinical investigation.

[57]  S. Lillioja,et al.  Relationship between degree of obesity and in vivo insulin action in man. , 1985, The American journal of physiology.

[58]  M. Lan,et al.  Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Mahan,et al.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. , 1964, Diabetes.

[60]  L. Bouter,et al.  Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study , 1996, Diabetologia.

[61]  A. Fontbonne,et al.  Risk Factors for NIDDM in White Population: Paris Prospective Study , 1991, Diabetes.

[62]  J. A. Scarlett,et al.  Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus. , 1982, The American journal of physiology.

[63]  N. Maclaren,et al.  Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. , 1996, The Journal of clinical endocrinology and metabolism.

[64]  Simeon I. Taylor,et al.  Lilly Lecture: Molecular Mechanisms of Insulin Resistance: Lessons From Patients With Mutations in the Insulin-Receptor Gene , 1992, Diabetes.

[65]  R. Rizza,et al.  Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[66]  C. Perronne,et al.  Pentamidine-Induced Derangements of Glucose Homeostasis: Determinant roles of renal failure and drug accumulation: A study of 128 patients , 1995, Diabetes Care.

[67]  S. Shoelson,et al.  Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. , 1984, The Journal of clinical investigation.

[68]  L. Niskanen,et al.  Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in Type 2 (non-insulin-dependent) diabetic and non-diabetic subjects , 1993, Diabetologia.

[69]  P. Hall,et al.  PREVALENCE OF GENETIC HAEMOCHROMATOSIS AMONG DIABETIC PATIENTS , 1989, The Lancet.

[70]  M. Engelgau,et al.  The Epidemiology of Diabetes and Pregnancy in the U.S., 1988 , 1995, Diabetes Care.

[71]  M. Engelgau,et al.  Comparison of Fasting and 2-Hour Glucose and HbA1c Levels for Diagnosing Diabetes: Diagnostic criteria and performance revisited , 1997, Diabetes Care.

[72]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[73]  R. Rao,et al.  Malnutrition and Diabetes in the Tropics , 1996, Diabetes Care.

[74]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[75]  K. Clément,et al.  Assessment of insulin sensitivity in glucokinase-deficient subjects , 1996, Diabetologia.

[76]  Ji-Woon Yoon,et al.  ASSOCIATION OF CYTOMEGALOVIRUS INFECTION WITH AUTOIMMUNE TYPE 1 DIABETES , 1988, The Lancet.

[77]  B. Balkau,et al.  Revision of diagnostic criteria for diabetes , 1996, The Lancet.

[78]  P. Pisters,et al.  Insulin secretion and action in patients with pancreatic cancer , 1991, Cancer.

[79]  P. Bingley,et al.  Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives , 1994, Diabetes.

[80]  R. DeFronzo,et al.  Mechanism of improvement in glucose metabolism after chronic glyburide therapy. , 1984, Diabetes.

[81]  M. Atkinson,et al.  The pathogenesis of insulin-dependent diabetes mellitus. , 1994, The New England journal of medicine.

[82]  H. Chase,et al.  Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies , 1996, Diabetes.

[83]  K. Segal,et al.  Evidence for Distinctive and Intrinsic Defects in Insulin Action in Polycystic Ovary Syndrome , 1992, Diabetes.

[84]  M. Stoffel,et al.  Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1) , 1996, Nature.

[85]  J. Olefsky,et al.  Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[86]  M. Harris.  Impaired Glucose Tolerance in the U. S. Population , 1989, Diabetes Care.

[87]  Insulin-Sensitive and Insulin-Resistant Variants in NIDDM , 1989, Diabetes.

[88]  S. Larsen,et al.  Metabolic control and B cell function in patients with insulin-dependent diabetes mellitus secondary to chronic pancreatitis. , 1987, Metabolism: clinical and experimental.

[89]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[90]  A. Hattersley,et al.  Altered Insulin Secretory Responses to Glucose in Diabetic and Nondiabetic Subjects With Mutations in the Diabetes Susceptibility Gene MODY3 on Chromosome 12 , 1996, Diabetes.

[91]  S. Baekkeskov,et al.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins , 1982, Nature.

[92]  L. Harrison,et al.  Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM? , 1994, Journal of autoimmunity.

[93]  P. Wahl,et al.  Prevalence of Complications Among Second-Generation Japanese-American Men With Diabetes, Impaired Glucose Tolerance, or Normal Glucose Tolerance , 1987, Diabetes.

[94]  M. Menser,et al.  High frequency of diabetes mellitus in young adults with congenital rubella. , 1971, Lancet.

[95]  J. Halter,et al.  Abnormal Insulin Secretion, Not Insulin Resistance, Is the Genetic or Primary Defect of MODY in the RW Pedigree , 1994, Diabetes.

[96]  R. Klein.  Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[97]  T. Shiba,et al.  Onset of diabetes with high titer anti-GAD antibody after IFN therapy for chronic hepatitis. , 1995, Diabetes research and clinical practice.

[98]  Janis F. Yao,et al.  Toward universal criteria for gestational diabetes: the 75-gram glucose tolerance test in pregnancy. , 1995, American journal of obstetrics and gynecology.

[99]  M. Stoffel,et al.  Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[100]  D. Steiner,et al.  Studies on mutant human insulin genes: identification and sequence analysis of a gene encoding [SerB24]insulin. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[101]  C. Jackson,et al.  A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. , 1992, Diabetes research and clinical practice.

[102]  G. Umpierrez,et al.  Diabetic Ketoacidosis in Obese African-Americans , 1995, Diabetes.

[103]  M. Lan,et al.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[104]  T. Barrett,et al.  Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome , 1995, The Lancet.

[105]  K. Narayan,et al.  Comparison of World Health Organization and National Diabetes Data Group Procedures to Detect Abnormalities of Glucose Tolerance During Pregnancy , 1994, Diabetes Care.

[106]  M. Rowley,et al.  Latent Autoimmune Diabetes Mellitus in Adults (LADA): the Role of Antibodies to Glutamic Acid Decarboxylase in Diagnosis and Prediction of Insulin Dependency , 1994, Diabetic medicine : a journal of the British Diabetic Association.

[107]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[108]  A. Peiris,et al.  Drug-Induced Disorders of Glucose Tolerance , 1993, Annals of Internal Medicine.

[109]  R. Hanson,et al.  Diagnosing diabetes mellitus – do we need new criteria? , 1997, Diabetologia.

[110]  R. Hanson,et al.  Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes , 1994, BMJ.

[111]  W. Knowler.  Screening for NIDDM: Opportunities for detection, treatment, and prevention , 1994, Diabetes Care.

[112]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[113]  T. Hansen,et al.  Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3) , 1996, Nature.

[114]  A. Moossa,et al.  A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma , 1978, The American Journal of Digestive Diseases.

[115]  M. Rowley,et al.  GAD Antibody Negative NIDDM in Adult Black Subjects with Diabetic Ketoacidosis and Increased Frequency of Human Leukocyte Antigen DR3 and DR4: Flatbush Diabetes , 1994, Diabetes.